CIR.L实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 08:00):

Stats
今日成交量	4 514.00
平均成交量	458 492
市值	0.00
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	34.00
ATR14	£0 (0.00%)

Circassia Group PLC 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Circassia Group PLC 财务报表

Annual	2021
营收:	£27.90M
毛利润:	£19.00M (68.10 %)
EPS:	£0.0100

FY	2021
营收:	£27.90M
毛利润:	£19.00M (68.10 %)
EPS:	£0.0100

FY	2020
营收:	£23.90M
毛利润:	£16.30M (68.20 %)
EPS:	£-0.0900

FY	2019
营收:	£62.40M
毛利润:	£46.20M (74.04 %)
EPS:	£-0.130

Financial Reports:

No articles found.

Circassia Group PLC

Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.